Study to evaluate efficacy & safety of tralokinumab in subjects with asthma inadequately controlled on corticosteroids

Trial Identifier: D2210C00014
Sponsor: AstraZeneca
NCTID:: NCT02449473
Start Date: September 2015
Primary Completion Date: June 2017
Study Completion Date: June 2017
Condition: Asthma

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
Canada, AB Calgary, AB, Canada, T2N 4Z6
Canada, BC Vancouver, BC, Canada, V5Z 1M9
Canada, ON Hamilton, ON, Canada, L8N 4A6
Canada, QC Montreal, QC, Canada, H4A 3J1
Canada, QC Quebec, QC, Canada, G1V 4G5
Denmark Ålborg, Denmark, 9000
Denmark Århus C, Denmark, 8000
Denmark Hvidovre, Denmark, 2650
Denmark København NV, Denmark, 2400
Denmark Odense C, Denmark, 5000
Denmark Silkeborg, Denmark, 8600
United Kingdom Belfast, United Kingdom, BT12 6BA
United Kingdom Birmingham, United Kingdom, B9 5SS
United Kingdom Glasgow, United Kingdom, G12 OYN
United Kingdom Leicester, United Kingdom, LE3 9QP
United Kingdom Liverpool, United Kingdom, L7 8XP
United Kingdom London, United Kingdom, NW1 2WU
United Kingdom London, United Kingdom
United Kingdom Manchester, United Kingdom, M23 9QZ
United Kingdom Nottingham, United Kingdom, NG5 1PB
United Kingdom Southampton, United Kingdom, SO16 6YD